Hymon Respiratory Triplex Panel Test Kit

Products

Hymon Respiratory Triplex Panel Test Kit

Short Description:

Hymon® Respiratory Triplex Panel Test Kit applies innovative “one-step method” to solve the cumbersome problem of nucleic acid extraction for SARS-CoV-2, influenza A and influenza B viruses; The nucleic acid is automatically   released in 3 minutes, with sample-to-results as short as 35 minutes.  Based on MoLock (nano-antibody molecular lock technology) and dual internal standard design, it achieves high sensitivity, high specificity, and full-process monitoring. A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses by multiplex testing.


Product Detail

Product Tags

Technical Advantages

Rapid detection

Simultaneous detection of all three pathogens completed with an innovative and exclusive one-step methodRNA processing completed in minutes, with sample-to-results in 35 minutes.

One-tube multiplex testing

A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses.

Accurate and safe

Full coverage of genes, multiplex detection, and multiple guarantees, among which the SARS-CoV-2 test has been approved by the FDA.

Multiple monitoring

Operation quality control includes three internal standards: positive control, negative control, and human DNA gene sequence. 

Unique technology

Nanobody molecular locking technology (MoLock) improves sensitivity and specificity.

 High sensitivity

Sensitivity reaches 5 copies/reaction.

 CE Certification

Clinical Application

The Respiratory Triplex Panel Test Kit for COVID-19 and influenza A/B detects multiple pathogens in one tube, accurately distinguishes COVID-19 from HBV viruses, assists doctors in diagnosing disease, and provide a reliable basis for epidemic prevention and control and clinical treatment.


  • Previous:
  • Next:

  • Write your message here and send it to us